Novartis News
Most Popular Novartis Story
Novartis VC arm backs fledgling universal flu vax
The venture arm of Novartis has joined a group of investors channeling $13.6 million in fresh funds for Immune Targeting Systems, which is hard at work on an experimental universal flu vaccine. ITS... Read more...
Latest Headlines
- February 17, 2010
- December 2, 2009
- November 5, 2009
- September 3, 2009
- August 6, 2009
- August 5, 2009
- July 16, 2009
- July 2, 2009
- June 11, 2009
- May 28, 2009
- April 30, 2009
- April 1, 2009
- February 11, 2009
- January 15, 2009
- September 25, 2008
- September 11, 2008
- July 24, 2008
- June 19, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
